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Aminoacyl-tRNA-protein transferases (Arg-trans- 
ferases) catalyze post-translational conjugation of spe- 
cific amino acids to the amino termini of acceptor 
proteins. A function of these enzymes in eukaryotes 
has been shown to involve the conjugation of destabi- 
lizing amino acids to the amino termini of short-lived 
proteins, these reactions being a part of the N-end rule 
pathway of protein degradation (Gonda, D. K., Bach- 
mair, A., Wiinning, I., Tobias, J. W., Lane, W. S., and 
Varshavsky, A. (1989) J. Biol. Chem. 264, 16700- 
16712). We have cloned the ATE1 gene of the yeast 
Saccharomyces cerevisiae which encodes arginyl- 
tRNA-protein transferase. ATE1 gives rise to a -1.6- 
kilobase mRNA and codes for a 503-residue protein. 
Expression of the yeast ATE1 gene in Escherichia coti, 
which lacks Arg-transferases, was used to show that 
the ATE 1 protein possesses the Arg-transferase activ- 
ity. Null ate1 mutants are viable but lack the Arg- 
transferase activity and are unable to degrade those 
substrates of the N-end rule pathway that start with 
residues recognized by the Arg-transferase. 
It has been known for many years that both bacteria and 
eukaryotes contain aminoacyl-tRNA-protein transferases, en- 
zymes that, catalyze post-translational conjugation of specific 
amino acids to amino termini of acceptor proteins (Kaji et al. 
1963, 1965; Hird et al., 1964; reviewed by Soffer, 1974, 1980; 
Deutch, 1984). This amino acid-protein conjugation is greatly 
enhanced in stressed or regenerating animal tissues, for in- 
stance, in physically injured neuronal axons (Ingoglia et al., 
1983; Zanakis et al., 1984; Shyne-Athwal et al., 1986; Chak- 
raborty et al., 1986). Furthermore, in studies initially uncon- 
nected to the problem of amino acid-protein conjugation, it 
has been found that ubiquitin-dependent degradation of some 
proteins in reticulocyte extracts requires the presence of 
tRNA (Ferber and Ciechanover, 1986). Discovery of the N- 
end rule of protein degradation (Bachmair et al., 1986) pro- 
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Savage et al. (1983) have isolated a yeast (Saccharomyces 
cereuisiae) mutant that had no obvious phenotype other than 
the virtual absence of the Arg-transferase’ activity in cell-free 
extracts. A wild-type version of the mutant gene has been 
named ATE1 and genetically mapped to a locus on chromo- 
some VII, near the LEUl gene (Savage et al., 1983). 
We now report the cloning of the S. cerevisiae ATE1 gene, 
show that it encodes Arg-tRNA-protein transferase, and de- 
scribe the results of an ate2 null phenotype analysis. We also 
The nucleotide sequence(s) reported in this paper has been submitted 
to the GenBankTM/EMBL Data Bank with accession number(s) 
505404. 
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vided an explanation for these observations and suggested a 
function for aminoacyl-tRNA-protein transferases. Specifi- 
cally, it has been shown that in both yeast and mammalian 
cells, an important component of the degradation signal in a 
short-lived protein is the protein’s amino-terminal residue 
(Bachmair et al., 1986; Varshavsky et al., 1988; Reiss et al., 
1988; Gonda et al., 1989; Chau et al., 1989; Bachmair and 
Varshavsky, 1989). The resulting code or rule that relates the 
protein’s metabolic stability and the nature of its amino- 
terminal residue has been called the N-end rule. It has also 
been suggested (Bachmair et al., 1986) and confirmed (Ferber 
and Ciechanover, 1987; Gonda et al., 1989) that some of the 
destabilizing amino-terminal residues in proteins are not di- 
rectly destabilizing as such but become so only through their 
ability to be conjugated, via an aminoacyl-tRNA-protein 
transferase, to other, primary destabilizing residues. Amino- 
terminal glutamic acid and aspartic acid (and also cysteine in 
mammalian reticulocytes) have been shown to be the second- 
ary destabilizing residues in that they are destabilizing 
through their ability to be conjugated, via an arginyl-tRNA- 
protein-transferase, to arginine, a primary destabilizing resi- 
due (Ciechanover et al., 1988; Gonda et al., 1989). Amino- 
terminal glutamine and asparagine have been shown, in both 
yeast and mammalian cells, to be the tertiary destabilizing 
residues in that they are converted, via selective deamidation, 
into the secondary destabilizing residues glutamic acid and 
aspartic acid (Gonda et al., 1989). 
Although the existence of several distinct aminoacyl-tRNA- 
protein-transferase activities has been inferred previously 
from a variety of evidence in both eukaryotic and prokaryotic 
cells (see “Discussion”), the only transferases that have ac- 
tually been purified and characterized in some detail are the 
arginyl-tRNA-protein-transferase in eukaryotes and the leu- 
cyl, phenylalanyl-tRNA-protein-transferase in bacteria (re- 
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consider the potential diversity of amino acid conjugation 
reactions in uivo and functional implications of such diversity. 
EXPERIMENTAL PROCEDURES 
Yeast and Bacteriul Strains-The S. cerevisiae ate1 mutant (strain 
M522: MATa ateel his7 [KIL-11 (Savage et ai., 1983)) was kindly 
provided by Dr. M. J. Leihowitz (Rutgers University, Piscataway, 
NJ). The ate1 strain U288-12A (MATn &eel ura.3 his7), used for 
transformation according to Dieckman and Tsagoloff (19&X3), has 
been obtained bv a cross between M522 and 22295-C (MATa ura3) 
and was a gift from Dr. S. Uiaszewski (University of Wroclaw, 
Poland). The strains 22295-C (M&a uro3) and US86 (MATol/MATa 
ura3/ura3) were used for ATE1 gene disruption. The strains IL125- 
2B (MATol his 1 w’) and 21278b (MAT@) were used as additional 
controls for wild-type levels of the Arg-transferase activity. YPD 
medium contained 2% glucose, 1% Bacto-yeast extract, and 2% 
Bacto-peptone. SD medium contained 2% glucose, 0.67% Difco yeast 
nitrogen base without amino acids, and nutrients essential for auxo- 
trophic strains (Sherman et al., 1986). 
Transformation of Escherichia coli was carried out with either the 
HBlOl strain, using the RbCl procedure (Maniatis et al., 1982) or 
with the strains BJH3 (for selection of URA3 plasmids), 71-28 (for 
selection of lacZ plasmids), and K38 (Tabor and Richardson, 1985) 
(for expression of ATE1 in E. coli). Transformation of the latter 
strains-was carried out using the CaClz procedure (Maniatis et al., 
1982). 
In Vitro Assay for Arg-transferase-The Arg-transferase activity 
was determined in crude extracts (Savage et al., 1983; Deutch, 1984). 
A stationary culture of S. cerevisiae grown at 30 “C in SD medium 
was centrifuged at 5,000 x g for 5 min. The pelleted cells (450 mg, 
wet weight) were resuspended in 0.5 ml of 6.25 M sucrose, 1 rnh 
EDTA. 1 mM phenvlmethvlsulfonvl fluoride (freshlv added from a 
0.1 M stock in isopropyl alcohol), 1 inM dithiothreitol;0.2 M Tris-HCl 
(pH 8.0). The suspension (0.9 ml) was degassed and thereafter shaken 
with 0.9 g of 0.45-mm glass beads in a Braun homogenizer (2 min 
total, with 3-s CO, cooling cycles between 20-s homogenizations). 
The suspension was adjusted to pH 7.5 with 1 N NaOH and centri- 
fuged at 80,000 x g for 50 min at 4 “C. The supernatant was adjusted 
to pH 9.0 with 1 N NaOH and used immediately for the Arg- 
transferase assay. A reagent for this assay, [14C]arginine-tRNA, was 
prepared in advance by incubating a supernatant from the extract of 
strain 21278b (obtained as above except for the resuspension of 
pelleted cells in 0.25 M glucose. 0.1 M Tris-HCl. DH 7.5) with 0.6 nmol 
bf L-[14C]arginine (Amersham’Corp., 342 mCijmmo1) and total yeast 
tRNA (Boehringer Mannheim) at 25 mg/ml for 45 min at 30 “C. The 
incubation mixture (0.2 ml) also contained 9 mM MgC12, 2 mM ATP, 
0.1 mM dithiothreitol, 0.1 M NaHEPES (pH 7.4), and 4.4 pM unla- 
beled arginine. After incubation, the sample was extracted with 
phenol, the RNA precipitated with ethanol, and redissolved in 50 mM 
Tris-HCl (pH 9.0) to -2,000 cpm/rl (-0.8 nM in Arg-tRNA). Under 
these conditions, -40% of the added [i4C]arginine was converted into 
[“C]Arg-tRNA. To measure the Arg-transferase activity, 0.17 ml of 
the yeast extract was incubated at 37 “C with [“C]Arg-tRNA 
(-40,000 cpm) and 84 mg/ml bovine serum albumin (the unlabeled 
arginine acceptor whose amino-terminal residue is aspartic acid) in a 
total volume of 0.5 ml containing also 0.15 M KCl, 50 mM P-mercap- 
toethanol, 50 mM Tris-HCl (pH 9.0). Yeast extract and the rest of 
the incubation mixture were-preincubated separately for 3 min at 
37 “C. Samples (0.1 ml) were withdrawn at different incubation times. 
spotted on Whatman 3 MM filters, and assayed for hot trichloroacetic 
acid-insoluble radioactivity (Deutch, 1984). In some experiments, the 
Arg-transferase assay was carried out as described below for E. coli 
except that S. cereuisiae cells were used. 
Cloning and Disruption of the ATE1 Gene-The cosmid cosA and 
its subclones pA-X28, pA-X14, pA-B6.5, pA-B8, and PA-B9 (Balzi et 
al., 1987) encompass the -35-kb region from LEUI to TRP5 on 
chromosome VII of S. cereuisiue (strain IL125-2B). For subcloning of 
the ATE1 gene, two additional plasmids were constructed: (i) pA-H4, 
produced by inserting the -4-kb, HindIII-produced H4 fragment of 
pA-X14 into the Hind111 site of pHCG3 (Gerbaud et al., 1981); (ii) 
pA-XS, produced by Sal1 digestion of pA-X14 (Balzi et al., 1987) and 
religation. 
The gene disruption method of Rothstein (1983) was used to 
generate null ate1 mutants. The H4 fragment of pA-X14 was inserted 
at the Hind111 site of a pBR322 derivative in which the BamHI site 
has been eliminated by digesting pBR322 with BamHI and EcoRV, 
blunting the ends, and religating (Maniatis et al., 1982; Ausubel et 
al., 1987). The ATEZ gene, contained within the H4 fragment (see 
“Results”), was then disrupted in uitro by the insertion, at its single 
BanHI site, of the URAS-containing 1.17-kb BglII fragment excised 
from pFL44 (a gift from Dr. F. Lacroute, Centre de Biologie Mole- 
culaire, Gif-sur-Yvette, France). The resulting plasmid, pA- 
H4::URA3, was digested with HindIII, and the 5.17-kb Hind111 frag- 
ment was transformed into strains 22295-C and US86 Ura’ trans- 
formants were isolated and tested for the Arg-transferase activity as 
described below for the expression of ATE1 in E. c&i. 
Sequencing the ATE1 Gene-The ATEl-containing H4 fragment 
of DA-H4 (Fig. 1) was inserted into the ulasmids DTZ~~R and uTZ19U 
(U&ed States Biochemical Corp., Cleveland, dH) to yield pTZlSR- 
H4 and pTZlSU-H4, respectively. The plasmid pTZ18R-H4 was 
digested with BamHI and Hind111 and religated to yield pTZ-HB1.2, 
which contained the -1.2.kb, 5’-proximal portion of ATEI (the 
HB1.2 fragment). Synthetic 15.nucleotide primers complementary to 
regions of the HB1.2 fragment were produced by Eurogentec (Liege, 
Belgium). The -4.5-kb SalI/BamHI fragment containing the 3’- 
proximal portion of the ATE1 was inserted into pTZ18U, to yield 
pTZ-SB4.5, and was then progressively deleted as described by Barnes 
et al. (1983). The inserts of pTZlSU-H4, pTZ-HB1.2, and the deletion 
derivatives of pTZ-SB4.5 were sequenced on both strands using the 
chain termination method (Ausubel et al., 1987). Computer analysis 
of the ATE1 sequence and its comparisons with other sequenced 
genes were carried out using either the PC/Gene or DNA-STAR 
programs, and the SWISS-PROT or NBRF-PIR data bases. 
Expression of ATE1 in E. coli-The ATEI-containing H4 fragment 
of PA-H4 was inserted. in either orientation. into the Hind111 site of 
pT712 (obtained from- GIBCO-Bethesda Research Laboratories) to 
yield the plasmids pTH4(+) andpTH4(-), in which the ATEl-coding 
strand was in either the correct or the opposite orientation, respec- 
tively, in relation to the T7 promoter of pT712. E. coli K38(pGPl-2) 
cells (Tabor and Richardson. 1985) were transformed with either 
pTH4(+) or pTH4(-) and grown at.30 “C in Luria broth containing 
30 pg/ml kanamycin and 100 rg/ml ampicillin (selective conditions 
for pGPl-2 and pT712, respectively). To induce the expression of 
ATEl, a lo-ml E. coli culture was grown to Am of -0.35, heated at 
42 “C for 15 min to derepress the T7 promoter (Tabor and Richard- 
son, 1985), and incubated for 3 min at 30 “C. Cells were pelleted by 
centrifugation, washed once with HZO, and resuspended in 0.3 ml of 
the assay buffer containing 0.12 M KCl, 10 mM MgC12, 4 mM dithio- 
threitol, 0.1 M Tris-HCl (pH 9.0), and 20 /*g/ml each of antipain, 
leupeptin, aprotinin, chymostatin, and pepstatin (Sigma). Glass beads 
(0.15 ml) were added, and the suspension was vortexed at top speed 
for 50 s followed by centrifugation at 12,000 x g for 5 min at 4 “C. 
The supernatant (39 ~1) was immediately added to 11 ~1 of premixed 
regents, to yield the following final concentrations: 1 X assay buffer; 
1 mg/ml total yeast tRNA (Sigma); 3 mM ATP; 0.2 mM puromycin; 
180 units/ml crude E. coli aminoacyl-tRNA synthetase (Sigma); 1 
mg/ml bovine serum albumin (the arginine acceptor); 1.5 &i/ml L- 
[“Clarginine (Amersham, 342 mCi/mmol). Reactions were carried 
out at 30°C. Samples (18 ~1) taken at 0, 10, and 25 min of incubation 
were spotted onto Whatman 3MM filters and assayed for hot trichlo- 
roacetic acid-insoluble radioactivity (Deutch, 1984). The 25-min sam- 
ples were also fractionated by electrophoresis in an 18% polyacryl- 
amide-SDS gel, followed by fluorography, to monitor the arginylation 
of the added bovine serum albumin. 
Determination of in Viuo Leuels of X-@gal Test Proteins in S. 
cerevisiae-Unlike the parental strain 22295-C (Muta ATE1 uru3), 
its derivatives, the atel-Al, atel-A2, and atel-A3 strains, were Ura’ 
because URA3 was used to disrupt the ATE1 gene in these strains 
(see “Results”). To make possible the transformation with URA3- 
based plasmids, the atel-Al strain was transferred onto YPD plates 
containing 5-fluoroorotic acid (Boeke et al., 1987), and Ura- mutants 
were isolated. Southern hybridization using either URA3 or ATE1 as 
probes showed that mutations to the Ura- phenotype in these deriv- 
atives of the atel-Al stain were not accompanied by excision of URA3 
from the disrupted ATE1 locus (data not shown). A Ura- derivative 
of the atel-Al strain and the parental strain 22295-C (Mata ATE1 
ura3) were transformed with yeast expression vectors encoding 
ubiquitin-X-/3-galactosidase (Ub-X-Bgal) proteins (Bachmair et al., 
1986), where X was either arginine, aspartic acid, glutamic acid, 
asparagine, or glutamine. Two Ura+ isolates from each transformation 
were tested for-the level of @gal enzymatic activity present, essentially 
as described by Miller (1972). with the following modifications. An 
exponential culture of cells growing in SD medium containing 3% 
galactose instead of glucose was centrifuged, washed, and resuspended 
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FIG. 1. Plasmids used in cloning the ATE2 gene. The cosmid cosA carries a -35-kb insert encompassing 
the region between LEUI and TRP5 on the chromosome VII of S. cereuisiae. The positions and orientations of 
PMAI, LEUI, PDRZ, TRP5 (Balzi et aZ., 1987) and ATE1 (this work) are shown, The restriction map of cosA is 
as described previously (Balzi et al., 1987). Also shown are the inserts of subclones used in the present work. 
Inserts that complemented the ate1 mutation are indicated by thick lines. + indicates the junctions between two 
fragments present together on the same plasmid. 
added to 0.4 ml of the buffer (10 mM KCl, 50 mM 2-mercaptoethanol, 
1 mM MgSO.,, 0.1 M sodium phosphate, pH 7.0) in an Eppendorf tube. 
Two drops of chloroform and 30 ~1 of 0.1% SDS were added followed 
by vortexing for 10 s and the addition of 0.1 ml of o-nitrophenyl-fl- 
D-galactoside (4 mg/mI) in H,O. After incubation at 36 “C for 1 h, 
the reaction was terminated by the addition of 0.5 ml of 1 M Na&03. 
The sample was centrifuged at 12,000 x g for 30 s, and the absorbance 
of the supernatant at 420 nm was determined. 
Southern Hybridization and Other Procedures-Plasmids were iso- 
lated from E. coli as described by Birnboim and Doly (1979). Radio- 
active DNA probes were prepared by nick translation (Rigby et aZ., 
1977) with [-y-32P]dCTP. The S. cereuisiae genomic DNA was isolated 
as described by Davis et al. (1980), digested with either Hind111 or 
EcoRI, and processed for low stringency Southern hybridization as 
described by Ozkaynak et al. (1987). Filters containing blotted DNA 
were incubated with labeled DNA probes overnight at 42 “C in 30% 
formamide, 0.2% SDS, 5 X SSC (1 X SSC is 0.15 M NaCl, 15 mM 
sodium citrate, pH 7.0), 5 X Denhardt’s solution (Maniatis et al., 
1982), 50 mM Na,HPO, (pH 7.0) containing 0.5 mg/ml denatured 
salmon sperm DNA. The filters were washed four times at 65 “C, for 
30 min each, in 0.2% SDS, 1 x SSC. For Northern analyses, total 
RNA was isolated from a stationary culture of the Y55-1163 strain 
of S. cereuisiae (HO, adel-1 ura3-1) as described by Maccecchini et 
al. (1979). The ATEI-specific radioactive probe was prepared by 
annealing the single-stranded plasmid pTZ-HB1.2 to a synthetic 15- 
nucleotide primer complementary to the ATE1 sequences between 
nucleotides 482 and 468 followed by the addition of the Klenow Pol 
I in the presence of [r-3ZP]dCTP and the three unlabeled dNTPs. 
The probe was heat denatured before hybridization, which was carried 
as described above, except that the washes were performed at 60 “C. 
RESULTS 
Isolation of the ATE1 Gene-By screening mutagenized S. 
cerevisiae for strains that show decreased activity of Arg- 
transferase in an in vitro assay, Savage et al. (1983) succeeded 
in isolating a mutant, which they called atel, that lacked the 
bulk of Arg-transferase activity in crude extracts. Aside from 
lacking most of the Arg-transferase activity, this mutant 
showed no obvious deviations from the parental phenotype. 
Genetic mapping of the ate1 mutation placed it near LEUl 
on chromosome VII (Savage et al., 1983). 
We have used a series of overlapping genomic DNA frag- 
ments encompassing the LEUl gene and the previously cloned 
(Balzi et al., 1987) -35-kb region centromere-distal to LEUl 
(Fig. 1) to transform the strain US%-12A that carried the 
original ate1 mutation of Savage et al. (1983). Several inde- 
pendent Ura+ transformants derived from each of the DNA 
subclones used (Fig. 1) were tested for the Arg-transferase 
activity in vitro (Fig. 2). The cosmid cosA, whose insert 
encompasses the entire -35kb region (Fig. I), conferred an 
increase of the Arg-transferase activity in the ate1 mutant to 
approximately wild-type levels (Fig. 2). Among the subclones 
of the cosA, the plasmid pA-X14 also complemented the Arg- 
transferase deficiency in the ate1 mutant, whereas pA-X28, 
pA-B6.5, pA-BS, and pA-XS did not (Fig. 2). Further sub- 
FIG. 2. Arg-transferase activity in different transformants 
of S. cereuisiae. cosA and its subclones shown in Fig. 1 were 
transformed into an ate1 mutant of S. cereuisiae (the US288-12A 
strain (MATa ate1 ura3 his7)), and the Arg-transferase activity in 
crude extracts was determined as described under “Experimental 
Procedures.” For each DNA subclone, the several values shown were 
obtained with independent transformants and are expressed as per- 
centages of the value (determined in the same experiment.) for an 
ATE1 strain IL125-2B (striped bar). The value for another ATE1 
strain (Z1278b) is also shown. Filled bars on the left indicate the 
relative Arg-transferase activities in extracts from strains carrying 
the original ate1 mutation (M522 and US288-12A). 
cloning of pA-Xl4 yielded the plasmid pA-H4, whose -4-kb 
insert was the smallest among the tested subclones that could 
restore high levels of the Arg-transferase activity in the ate1 
mutant (Fig. 2). Northern analysis showed that the corre- 
sponding region of chromosome VII in an ATE1 strain is 
transcribed in vivo to yield a -1.6-kb RNA (Fig. 3A). 
There are apparently no close homologs of ATE1 in the S. 
cerevisiae genome because a low stringency Southern hybrid- 
ization, using the full-length ATE1 as a probe, detected only 
ATE1 in the S. cerevisiae genomic DNA (Fig. 3B). This result 
is consistent with the absence of Arg-transferase activity in 
extracts from atel-A mutants and also with the metabolic 
stabilization in these mutants of X-pgal proteins bearing 
secondary or tertiary destabilizing amino-terminal residues 
(see below). 
The ATE1 Gene Encodes a 503-Residue Protein-The nu- 
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a a b 
FIG. 3. The ATE1 RNA and DNA. A, total RNA from an ATE1 
strain was fractionated by electrophoresis in a 1.6% agarose gel 
contaming 6% formaldehyde (Maniatis et al., 1982), transferred to a 
mtrocellulose filter, and hybridized to an ATE:J-specific probe (see 
“Experimental Procedures”). Arrouheadc mdicate the positions of 
yeast rRNAs (1789 and 3392 nucleotides, respectively). Using these 
markers, the ATE1 transcript (indicated by an arrow) was estimated 
to he -1.6 kh long. H, Southern hybridization analysis. Purified S 
CCWL’~.S(Q~ DNA was digested with either HzndIII (lane a) or EtoRI 
(Jane h), fractionated by electrophoresis in an agarose gel, transferred 
to a filter, and hybridized to an ATEJ-specific probe under low 
stringency conditions (see “Experimental Procedures”). 
determined as described under “Experimental Procedures.” 
The ATE1 gene appears to encode a 503-residue protein (Fig. 
4), with a calculated molecular mass of 57,866 daltons and a 
calculated isoelectric point of 5.86. The exact location of the 
start ATG codon in ATE1 is uncertain; the choice shown in 
Fig. 4 yielded the longest uninterrupted reading frame. The 
inferred size of the S. cereuisiae Arg-transferase (-58 kDa) is 
larger than those reported for the mammalian Arg-transfer- 
ases from rabbit liver (-50 kDa) (Soffer, 1980) and hog kidney 
(-35 kDa) (Kato and Nozawa, 1984). No sequences charac- 
teristic of membrane-spanning helical segments were detect- 
able in ATE1 using the algorithm of either Eisenberg et al. 
(1982) or Rao and Argos (1986). The ATE1 protein also lacks 
motifs characteristic of either an endoplasmic reticulum-tar- 
geting signal sequence (von Heijne, 1986) or nuclear translo- 
cation signals (Dingwall and Laskey, 1986; Guiochon-Mantel 
et al., 1989), suggesting that the ATE1 gene product is a 
cytoplasmic protein. This assignment is also consistent with 
the predicted function of Arg-transferase in the N-end rule 
pathway of protein degradation which operates in the cytosol 
and is apparently absent from membrane-enclosed compart- 
ments such as Golgi, lysosomes, and endoplasmic reticulum 
(Gonda et al., 1989). 
The codon bias index (Bennetzen and Hall, 1982) for ATE1 
is low (0.04), suggesting that ATE1 is a weakly expressed 
gene. No statistically significant homologies were found be- 
tween the amino acid sequence of ATE1 and those of known 
proteins using several data bases and the algorithm of Lipman 
and Pearson (1985). Similarities of marginal statistical sig- 
nificance were observed between ATE1 and several amino- 
acyl-tRNA synthetases, in particular the E. coli Arg-, Ala-, 
and Thr-tRNA synthetases and the Trp-tRNA synthetase 
from Bacillus stearothermophilus (data not shown). These 
similarities were not unexpected because aminoacyl-tRNA, 
the product of an aminoacyl-tRNA synthetase, is the sub- 
strate of the ATE1 enzyme. 
Flanking nucleotide sequences upstream and downstream 
of the ATE1 gene contain motifs characteristic of yeast pro- 
moter and terminator regions, respectively (Fig. 4). In partic- 
ular, a CT-rich tract (92% CT in a 36.nucleotide sequence) 
precedes by 90 base pairs the putative start codon of ATE1 
FIG. 4. Nucleotide sequence of the ATEI locus and deduced 
amino acid sequence of the ATE1 protein. The 2091-hp nucleo- 
tide sequence shown starts at the proximal Hind111 site of the yeast 
DNA insert in pA-H4 (see Fig. 1). The initiator methionine codon 
(pos&on 2 in the amino acid sequence) was assigned at this position 
because it yielded the longest uninterrupted reading frame. No se- 
quence motifs characteristic of yeast introns (Ballance, 1986) have 
been found in the -400.hp stretch of DNA upstream of the (inferred) 
initiator methionine codon of ATE]. The sequence motifs character- 
istic of S. ceremme promoters and terminators are underlmed, re- 
spectively, upstream and downstream of the ATE1 reading frame. 
The putative heat shock element, GAAtcTTC (Sorger and Nelson, 
1989; Perisic et al, 1989) is present near position -220. Note also the 
presence of another GAA sequence 3 nucleotides downstream from 
TTC. 
(Fig. 4). Similar tracts are present in many yeast promoter 
regions (Dobson et al., 1982; Oberto and Davison, 1985), where 
they appear to increase the fidelity of transcriptional initia- 
tion (McNeil, 1988). The same CT-rich region is also ex- 
tremely T-rich, with stretches of uninterrupted T-tracts up 
to 10 nucleotides longs (see Fig. 6). These sequence motifs 
may play a role in the regulation of constitutive transcription 
in S. cereuisiae (Struhl, 1985; Winter and Varshavsky, 1989; 
Lue et al., 1989). No TATA element, as defined by Chen and 
Struhl (1988), is evident in the (sequenced) region upstream 
of ATEI. A purine, adenine, is present at position -3, as 
observed with most eukaryotic genes (Dobson et al., 1982; 
Kozak, 1984). A potential heat shock element, a highly con- 
served DNA sequence that is apparently both necessary and 
sufficient for heat-inducible transcriptional activation (Per- 
isic et al., 1989; Sorger and Nelson, 1989) is present near 
position -220. Whether the ATE1 transcription is in fact 
regulated by temperature shifts or other stresses remains to 
be determined. In the 3’.noncoding region, the tripartite motif 
TAG . . TAGT . . TTT, a potential signal for transcription 
termination and polyadenylation (Zaret and Sherman, 1982), 
is present 91 base pairs downstream from the TGA stop codon 
of ATEl. 
Construction and Analysis of atel-A Mutants-To generate 
a null allele of the ATE1 gene and also to verify that the 
plasmid pA-H4 (Figs. 1, 2, and 4) actually carried ATEl, we 
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placed the wild-type ATE1 allele in the yeast genome with 
the disrupted allele by homologous recombination (Rothstein, 
1983). The URA3 marker was inserted at the unique BumHI 
site of the -4-kb H4 fragment of pA-H4 which is located in 
the middle of the ATE1 reading frame (Fig. 5A). The -5.2- 
kb H4::URA3 fragment thus obtained was used to transform 
US86 and 22295-C, the diploid and haploid ATE1 ura3 
strains, respectively. Stable Ura+ transformants were ob- 
tained with both of these strains, indicating that the disrup- 
tion of ATE1 is compatible with cell viability. The haploid 
Ura+ transformants of the strain 22295-C were screened by 
Southern hybridization for the presence of restriction endo- 
nuclease sites diagnostic of the ATE1 gene disruption (Fig. 5, 
A and B). For three of the four Ura+ transformants tested 
(strains atel-Al, atel-A2, and atel-A3), the analysis con- 
firmed that the -5.2-kb H4::URA3 fragment had integrated 
at the ATE1 locus on chromosome VII, where it replaced the 
resident ATE1 gene (Fig. 5, A and B). 
The 22295-C (ATEl) strain and its ate1 -A derivatives were 
also tested for the Arg-transferase activity in crude extracts. 
The level of Arg-transferase activity in the atel-A mutants 
(Fig. 5C) was indistinguishable from the background levels of 
[ ‘Hlarginine incorporation in extracts of E. coli which appar- 
ently lacks Arg-transferase (Soffer, 1980). 
Expression of ATE1 in E. coli-To verify directly that the 
cloned S. cerevisiae ATE1 gene encodes an Arg-transferase, 
the gene was expressed in E. coli. The -4-kb Hind111 fragment 
of pA-H4 which encompasses the ATE1 gene was inserted 
into the expression vector pT712 (Tabor and Richardson, 
1985) downstream of the T7 RNA polymerase promoter. The 
A TEl -containing fragment was inserted in both orientations, 
yielding the plasmids pTH4(+) and pTH4(-), with the former 
plasmid having ATE1 oriented correctly in relation to the T7 
promoter (see “Experimental Procedures”). These plasmids 
were transformed into the E. coli K38 host, which carries 
pGPl-2, a plasmid that encodes the phage T7 RNA polym- 
erase under the control of the inducible XPL promoter (Tabor 
and Richardson, 1985). As shown in Fig. 6, extracts prepared 
from E. coli bearing the plasmids pGPl-2 and pTH4(+) 
contained the Arg-transferase activity. Much lower levels of 
the Arg-transferase activity were present in extracts from E. 
coli bearing the plasmids pGPl-2 and pTH4(-) (Fig. 6). That 
these levels were still greater than the background of the Arg- 
transferase assay (in extracts from cells lacking ATE1 plas- 
mids) (Fig. 6) could be explained by a “leaky” expression of 
ATE1 from a cryptic promoter in the pTH4(-) plasmid. 
We conclude that the ATE1 gene encodes Arg-transferase 
rather than an activator of the Arg-transferase expression or 
activity. 
Arg-transferase and the N-end Rule Pathway-S. cerevisiae 
mutants lacking the ATE1 -encoded Arg-transferase are viable 
and apparently normal phenotypically. They lack the Arg- 
transferase activity in crude extracts (Fig. 5C), suggesting, in 
agreement with the Southern hybridization data (Fig. 3B), 
that ATE1 is the only gene that encodes Arg-transferase in 
S. cerevisiae. 
Previous in vitro studies of the N-end rule pathway (Gonda 
et al., 1989; Ciechanover et al., 1988; Ferber and Ciechanover, 
1987; see the Introduction) have shown that amino-terminal 
aspartic acid and glutamic acid (and also cysteine in reticu- 
locytes) are secondary destabilizing residues in that they func- 
tion by virtue of their ability to be conjugated to a primary 
destabilizing residue, arginine. To determine whether ATE1 
is essential for this aspect of the N-end rule pathway in yeast, 
we transformed a Ura- derivative of the atel-Al strain (see 
“Experimental Procedures”) and its parental counterpart with 









FIG. 5. Disruption of Ate 1. A, diagram of expected recombina- 
tion events in the ATE1 disruption. The linear -5.2-kb Hind111 
fragment (H4::URA3) which was used to transform S. cereuisiae, 
contained the ATEZ gene (open bar) disrupted by the insertion of 
URA3 (striped box). Replacement of the wild-type ATE1 on chro- 
mosome VII (Chr VII H) with the disrupted ate1 allele (Chr VII D) 
was carried out as described under “Experimental Procedures.” As 
shown in the diagram, this replacement generates a new arrangement 
of the recognition sites for Hind111 (H), BamHI (B), and Sal1 (S). B, 
Southern hybridization analysis of the structure of the integrated 
atel::URA3 allele. Purified genomic DNA from the parental (haploid) 
strain 22295-C and from Ura’ derivatives of this strain (atel-M and 
atel-A2) obtained by transformation with pH4::URA3 (see “Experi- 
mental Procedures”) was digested with either HindIII, BarnHI, or 
SalI, fractionated by electrophoresis in a 0.9% agarose gel, and 
analyzed by Southern hybridization using the -1.2-kb BarnHI/ 
Hind111 fragment (a dashed segment in A) as a probe. Arrows mark 
the positions of diagnostic DNA fragments shown in A. C, Arg- 
transferase activity in extracts of the ATEI strain 22295-C and the 












































e .- 2000 
P 
4: 
2 I * 
w abcdef 
10 20 30 
Ttme (mm) 
FIG. 6. Expression of the S. cerevisiae ATE1 gene in E. coli. 
A, incorporation of [‘“Clarginine into hot trichloroacetic acid-insol- 
uble material by extracts of E. coli K38 bearing either pGPl-2 plus 
pTH(4+) (0 and 0) or pGPl-2 plus pTH4(-) (0 and W), with the 
open and closed symbols indicating extracts prepared from heat- 
treated and untreated E. coli, respectively. X, pGPl-2 alone (with 
either heat-treated or untreated E. coli). See “Experimental Proce- 
dures” for the assay used. B, proteins in equal volume, 25-min samples 
of panel A were fractionated by SDS-polyacrylamide gel electropho- 
resis followed by fluorography. An arroui indicates the 69-kDa band 
of bovine serum albumin, the added acceptor of [Wlarginine in the 
E. coli extracts (see “Experimental Procedures”). Lane designations 
on top correspond to the curve designations in panel A. Lane M 
contained “C-labeled molecular mass markers (Amersham). 
yeast expression vectors encoding ubiquitin-X-P-galactosid- 
ase (Ub-X-figal) proteins, where X was either arginine, aspar- 
tic acid, glutamic acid, asparagine, or glutamine. Previous 
work (Bachmair et al., 1986; Bachmair and Varshavsky, 1989) 
has shown that a nascent Ub-X-pgal fusion protein is effi- 
ciently deubiquitinated in vivo regardless of the nature of the 
amino acid residue X at the ubiquitin-figal junction. In con- 
trast to the function of ubiquitin at later stages of the degra- 
dative pathway (Chau et al., 1989), the role of ubiquitin in the 
ubiquitin-pgal fusion approach is simply to allow the genera- 
tion of the desired X-@gal test proteins through the action of 
a ubiquitin-specific processing protease (Bachmair et al., 1986; 
Gonda et al., 1989). Physiological functions of this protease 
include the analogous processing of natural ubiquitin precur- 
sors (ijzkaynak et al., 1987; Finley et al., 1988, 1989). 
To compare the metabolic stabilities of Arg-, Asp-, Glu-, 
Asn-, and Gln-bgal in the ATE1 and utel-A genetic back- 
grounds, we determined the concentrations of these X-pgal 
proteins in cells by measuring the enzymatic activity of Pgal 
in crude extracts (Fig. 7). Since all of these X-bgal proteins, 
which differ exclusively in their amino-terminal residues, were 
expressed using the same vector (Bachmair et al., 1986), the 
levels of @gal activity in different transformants growing 
under identical conditions and sampled at the same stage of 
exponential growth should reflect the metabolic stabilities of 
the corresponding X$gal proteins (Bachmair et al., 1986; and 
data not shown). 
Although Arg-pgal, the most metabolically unstable of X- 
Pgal proteins in yeast (& of -2 min) (Bachmair et al., 1986; 
Bachmair and Varshavsky, 1989) was present at extremely 
low steady-state levels in both ATE1 and atel-A genetic 
backgrounds, the levels of Asn-pgal were strikingly different 
in the ATE1 and atel-A strains (Fig. 7). Similar but smaller 
increases of @gal activity in the ate1 -A strain (correlating with 
the known half-lives of the corresponding X-bgal proteins in 
ATE1 cells; see the legend to Fig. 7) were also observed for 
Asp-, Glu-, and Gln-pgal, all of which, unlike Arg-@gal, have 
Arg ASP GlU As3 
FIG. 7. Null ate1 mutant does not degrade X-@gal test pro- 
teins that bear either secondary or tertiary destabilizing 
amino-terminal residues. The ATEI (22295-C, filled bars) and null 
ate1 (atel-11, striped bars) strains of S. cereuisiae were transformed 
with expression vectors encoding different Ub-X-figal proteins, and 
the enzymatic activity of flgal was determined in extracts from the 
transformants (see “Experimental Procedures”). Measurements were 
carried out with samples in duplicate; the values shown are each an 
average of two measurements that differed from each other by less 
than 7%. Note the increase of &al activity in ateI- cells for Asn- 
@gal, Gln-@gal, Asp-pgal, and GlurflGal but-not for Arg-/Jgal (see also 
“Results”). The in uiuo half-lives of Asn-. Gln-. Asn-. Glu-. and Arg- . . 
@gal in wild-type (ATEZ) S. cerevisiae at 30 “C ‘are -3, -10, -3, -30, 
and -2 min, respectively (Bachmair et al., 1986; Bachmair and 
Varshavsky, 1989). 
either secondary or tertiary destabilizing amino-terminal res- 
idues (see the Introduction). The levels of Asp-, Glu-, Asn-, 
or Gln-/3gal in the ate1 -A background were similar to the level 
of Met-@gal, which has a stabilizing amino-terminal residue 
and is long lived (& > 20 h) in both ATE1 and atel-A 
backgrounds (Fig. 7 and Bachmair et al., 1986). Thus, in the 
absence of the ATEl-encoded Arg-transferase, both the ter- 
tiary (asparagine, glutamine) and the secondary (aspartic acid, 
glutamic acid) destabilizing residues become stabilizing ones 
in vivo, as suggested previously on the basis of in vitro data 
(Gonda et al., 1989). 
DISCUSSION 
The yeast arginyl-tRNA-protein transferase, whose gene, 
ATEI, has been cloned and functionally characterized in the 
present work, is a -58-kDa enzyme whose (inferred) substrate 
specificity is similar to those of the higher eukaryotic Arg- 
transferases (Soffer, 1980). The latter enzymes (whose genes 
have not yet been cloned) have been isolated from protozoans, 
plants, and several mammalian tissues and cell lines (Deutch 
et al., 1978; Soffer, 1980; Kato and Nozawa, 1984; Ciechanover 
et al., 1988). One of the better characterized Arg-transferases, 
isolated from rabbit reticulocytes, is copurified with Arg- 
tRNA synthetase and appears to exist as a -400-kDa heter- 
omeric complex between several molecules of Arg-transferase 
and Arg-tRNA synthetase (Ciechanover et al., 1988). 
As described in the Introduction, the in vitro evidence 
(Gonda et al., 1989; Ciechanover et al., 1988) strongly sug- 
gested that Arg-transferase functions in the N-end rule path- 
way of protein degradation, where it conjugates arginine, a 
primary destabilizing residue, to amino termini of proteins 
bearing secondary destabilizing residues aspartic acid or glu- 
tamic acid (and also cysteine in reticulocytes). By construct- 
ing and analyzing atel-A mutants in S. cerevisiae, we have 
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for this aspect of the N-end rule pathway. Whether this is the 
only function of the Arg-transferase remains to be deter- 
mined. 
The lack of ATE1 homologs detectable by a low stringency 
Southern hybridization in the S. cereuisiae genomic DNA 
(Fig. 3B) and the absence of Arg-transferase activity in ex- 
tracts from atel-A mutants (Fig. 5C) suggested that ATE1 is 
the only aminoacyl-tRNA-protein transferase in this orga- 
nism. This possibility is also consistent with the strong met- 
abolic stabilization of X-/3gal proteins bearing secondary and 
tertiary destabilizing amino-terminal residues in the atel-A 
genetic background (Fig. 7). On the other hand, in higher 
eukaroytes such as mammals, fishes, and mollusks, a variety 
of amino acids, in addition to arginine, have been reported to 
be post-translationally conjugated to proteins (Laughrea, 
1982; Ingoglia et al., 1983; Jackson and Hunt, 1983; Shyne- 
Athwal et al., 1986). In none of these “non-Arg” conjugation 
reactions (with the exception of the conjugation of tyrosine 
to the carboxyl terminus of tubulin (Kumar and Flavin, 1981; 
Nath et al., 1989)) have the relevant enzymes been purified 
or otherwise characterized (see also Rapaport et al., 1985). 
The functions of these putative conjugation reactions and 
physiological substrates involved remain to be addressed. 
Bacteria such as E. coli lack Arg-transferase but contain a 
leucyl,phenylalanyl-tRNA-protein transferase which is ap- 
parently absent from eukaryotes. In uitro, this enzyme can 
conjugate either leucine, phenylalanine, or methionine to 
amino-terminal arginine, lysine, or histidine in proteins or 
peptides (Leibowitz and Soffer, 1970; Soffer, 1980; Belitsina, 
1988). E. coli mutants deficient in the Leu,Phe-transferase 
are viable but abnormal in several respects (Soffer, 1980). If 
bacteria possess the N-end rule pathway (a possibility being 
tested),2 the function of the Leu,Phe-transferase might be 
analogous to that of the Arg-transferase in eukaryotes, with 
the amino-terminal arginine, lysine, and histidine now being 
secondary destabilizing residues, conjugated to the primary 
destabilizing residues leucine or phenylalanine (in contrast to 
the arginine, lysine, and histidine being primary destabilizing 
residues in the eukaryotic N-end rule pathway (Gonda et al., 
1989)). 
Physiologically relevant substrates of Arg-transferases re- 
main to be identified. All of the currently used substrates of 
Arg-transferases are either deliberately engineered proteins 
bearing amino-terminal aspartic acid, glutamic acid, or cys- 
teine (Gonda et al., 1989) or natural compartmentalized pro- 
teins (Ciechanover et al., 1988; Soffer, 1980) whose amino- 
terminal residues are often aspartic acid or glutamic acid, but 
whose normal intracellular location is expected to preclude 
their contact with the cytosolic Arg-transferase and the rest 
of the N-end rule pathway in uiuo. Physiological functions of 
the N-end rule pathway, of which the Arg-transferase is a 
component, are also unknown (see discussion by Gonda et al., 
1989). Mutational inactivation of the N-end rule pathway in 
S. cereuisiue has recently been shown to result in viable cells,3 
implying that the in uiuo degradation of physiological sub- 
strates of the N-end rule pathway (which are expected to 
include substrates of the Arg-transferase) is either nonessen- 
tial for cell growth and division or, alternatively, can take 
place in the absence of the N-end rule pathway because the 
short-lived proteins involved may each carry more than one 
degradation signal. A precedent for this possibility is provided 
by the recent analysis of the yeast MATa repressor that has 
been shown to possess two degradation signals operating via 
’ J. W. Tobias and A. Varshavsky, unpublished results. 
3 B. Bartel, I. Wiinning, and A. Varshavsky, unpublished results. 
distinct pathways.4 One function of the N-end rule pathway 
which is consistent with the available evidence may involve 
selective destruction of otherwise long-lived proteins that 
mislocalize into cytosol from vesicular compartments such as 
endoplasmic reticulum, Golgi, and vacuoles or lysosomes. It 
has been noted previously by Bachmair et al. (1986) that the 
amino-terminal residues of compartmentalized proteins are 
largely of the destabilizing type according to the N-end rule, 
in striking contrast to the amino-terminal residues of non- 
compartmentalized proteins which are almost exclusively of 
the stabilizing type. Biochemical and genetic searches for 
physiological substrates of the Arg-transferase and the N-end 
rule pathway are in progress. 
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